Shu Wang
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 5%
- Cancer Research top 10%
- Immunology
- Pathology and Forensic Medicine top 10%
- Co-authors
- Guang NingHaibao ZhuCia‐Hin LauFelix Chang TayAlice H. LichtensteinXiaohua JiangLei YeYichuan Xiao
- Topics
- Thyroid Cancer Diagnosis and Treatment (6 papers)MicroRNA in disease regulation (5 papers)Thyroid Disorders and Treatments (4 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Shu Wang
43 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 496
- Endocrinology, Diabetes and Metabolism 424
- Cancer Research 244
- Immunology 197
- Pathology and Forensic Medicine 185
Countries citing papers authored by Shu Wang
This map shows the geographic impact of Shu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Wang more than expected).
Fields of papers citing papers by Shu Wang
This network shows the impact of papers produced by Shu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Wang. The network helps show where Shu Wang may publish in the future.
Co-authorship network of co-authors of Shu Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Shu Wang. A scholar is included among the top collaborators of Shu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Wang. Shu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 7 | |
| 4 | 17 | |
| 5 | 2 | |
| 6 | 9 | |
| 7 | 32 | |
| 8 | 24 | |
| 9 | 23 | |
| 10 | 16 | |
| 11 | 1 | |
| 12 | 34 | |
| 13 | 119 | |
| 14 | 62 | |
| 15 | 20 | |
| 16 | 16 | |
| 17 | 2 | |
| 18 | 12 | |
| 19 | 5 | |
| 20 | 53 |
About Shu Wang
Shu Wang is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Immunology and Allergy, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (5 papers) and Thyroid Disorders and Treatments (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (424 citations), Cancer Research (244 citations) and Pathology and Forensic Medicine (185 citations). Shu Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Guang Ning, Haibao Zhu, Cia‐Hin Lau, Felix Chang Tay, Alice H. Lichtenstein, Xiaohua Jiang, Lei Ye, Yichuan Xiao, Yi Zhang and Hua Guo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.